102 related articles for article (PubMed ID: 23321888)
1. Crying and spilling--time to stop the overmedicalisation of normal infant behaviour.
Hudson B; Alderton A; Doocey C; Nicholson D; Toop L; Day AS
N Z Med J; 2012 Dec; 125(1367):119-26. PubMed ID: 23321888
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor utilization patterns in infants.
Barron JJ; Tan H; Spalding J; Bakst AW; Singer J
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):421-7. PubMed ID: 18030207
[TBL] [Abstract][Full Text] [Related]
3. [Omeprazole of limited value in crying babies].
Blokpoel RG; Broos N; de Jong-van den Berg LT; de Vries TW
Ned Tijdschr Geneeskd; 2010; 154():A1850. PubMed ID: 20719016
[TBL] [Abstract][Full Text] [Related]
4. [Adverse events associated with long-term use of proton pump inhibitors].
Reimer C; Bytzer P
Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
[TBL] [Abstract][Full Text] [Related]
6. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.
Hassall E
J Pediatr; 2012 Feb; 160(2):193-8. PubMed ID: 22018908
[No Abstract] [Full Text] [Related]
7. [Safety of proton pump inhibitors for long-term application].
Kuipers E
Eksp Klin Gastroenterol; 2006; (4):48-52. PubMed ID: 17269424
[No Abstract] [Full Text] [Related]
8. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
9. Natural history and familial relationships of infant spilling to 9 years of age.
Martin AJ; Pratt N; Kennedy JD; Ryan P; Ruffin RE; Miles H; Marley J
Pediatrics; 2002 Jun; 109(6):1061-7. PubMed ID: 12042543
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole for gastroesophageal reflux disease in the first 2 years of life: a dose-finding study with dual-channel pH monitoring.
Bishop J; Furman M; Thomson M
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):50-5. PubMed ID: 17592364
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
[TBL] [Abstract][Full Text] [Related]
12. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
13. Excessive crying and gastro-oesophageal reflux disease in infants: misalignment of biology and culture.
Douglas PS
Med Hypotheses; 2005; 64(5):887-98. PubMed ID: 15780481
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
Lundell L
Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
[No Abstract] [Full Text] [Related]
15. Proton pump inhibitors for irritable infants.
Smith CH; Israel DM; Schreiber R; Goldman RD
Can Fam Physician; 2013 Feb; 59(2):153-6. PubMed ID: 23418240
[TBL] [Abstract][Full Text] [Related]
16. Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs.
Thiéfin G; Schwalm MS
Dig Liver Dis; 2011 Mar; 43(3):209-14. PubMed ID: 21051300
[TBL] [Abstract][Full Text] [Related]
17. Nutritional consequences of long-term acid suppression; are they clinically important?
Johnson DA
Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397
[TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
[TBL] [Abstract][Full Text] [Related]
19. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
Orsi M; Donato G; Busoni V; Naisberg G; Caruso N
Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
[TBL] [Abstract][Full Text] [Related]
20. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
Wang L; Zhou L; Lin S; Hu H; Xia J
J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
